![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
OMBITASVIR/PARITAPREVIR/RITONAVIR FOR TREATMENT OF HCV GENOTYPE 1B IN JAPANESE PATIENTS WITH OR WITHOUT CIRRHOSIS: RESULTS FROM GIFT-I
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
K Chayama, F Suzuki, K Ikeda, H Toyoda, K Sato, Y Karino, Y Matsuzaki, K Kioka, T Pilot-Matias, C Setze, X Zhang, P Badri, T Yanke, T Matsuda, RA Vilchez, L Rodrigues-Jr, H Kumada
![EASL1.gif](../images/042815/042815-4/EASL1.gif)
![EASL2.gif](../images/042815/042815-4/EASL2.gif)
![EASL3.gif](../images/042815/042815-4/EASL3.gif)
![EASL4.gif](../images/042815/042815-4/EASL4.gif)
![EASL5.gif](../images/042815/042815-4/EASL5.gif)
![EASL6.gif](../images/042815/042815-4/EASL6.gif)
![EASL7.gif](../images/042815/042815-4/EASL7.gif)
![EASL8.gif](../images/042815/042815-4/EASL8.gif)
![EASL9.gif](../images/042815/042815-4/EASL9.gif)
![EASL10.gif](../images/042815/042815-4/EASL10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|